Trials / Recruiting
RecruitingNCT05959291
Discontinuation of Maintenance HER-2 Directed Therapy in Long-Term Survivors of Metastatic HER-2 Positive Breast Cancer
Free-HER: Discontinuation of Maintenance HER-2 Directed Therapy in Long-Term Survivors of Metastatic HER-2 Positive Breast Cancer
- Status
- Recruiting
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 20 (estimated)
- Sponsor
- University of Miami · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this preliminary research study is to see if patients discontinuing maintenance Herceptin and/or other anti-HER-2 treatments with monitoring in addition to radiologic imaging and routine blood work will stay in complete radiological remission and to determine how long patients are able to stay in complete radiological remission without treatment.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | Discontinuation of Anti-HER-2 Maintenance Treatment | Patients assigned to this group will be asked to discontinue anti-HER-2 maintenance treatment. |
Timeline
- Start date
- 2023-07-17
- Primary completion
- 2026-07-31
- Completion
- 2029-07-31
- First posted
- 2023-07-25
- Last updated
- 2025-08-13
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT05959291. Inclusion in this directory is not an endorsement.